Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: Type 508 Accommodation and the title of the report in the subject line of e-mail.

Announcements: Countermeasures Injury Compensation Program

The Countermeasures Injury Compensation Program (CICP) is a federal program that provides compensation for unreimbursed medical expenses, lost employment income, and/or death benefits for certain persons. These persons must have been seriously injured as a result of receiving covered countermeasures against certain pandemic, bioterrorism, or security threats specified by the Secretary of Health and Human Services through a Public Readiness and Emergency Preparedness (PREP) Act declaration.*

PREP Act declarations currently cover certain pandemic influenza countermeasures used to prevent, treat, or diagnose pandemic influenza such as influenza A (H1N1) 2009 monovalent vaccine, oseltamivir, zanamivir, peramivir, certain personal respiratory protection devices (e.g., N95 masks), certain respiratory support devices (e.g., mechanical ventilators), and certain diagnostic devices. Other PREP Act declarations cover certain vaccines, antimicrobials, antitoxins, drugs, diagnostics or devices used to identify, prevent, or treat smallpox, anthrax, botulism, or acute radiation syndrome. Injuries from certain other vaccines, including seasonal influenza, might be covered by the National Vaccine Injury Compensation Program (VICP), established by the National Childhood Vaccine Injury Act of 1986.

The CICP has a statutory 1-year filing deadline after the administration or use of the covered countermeasure that might have caused the injury. Until the federal regulations that implement the CICP are published in the Federal Register, injured persons can meet the filing deadline by submitting a Letter of Intent to File a Request for Benefits. Additional information regarding CICP is available at

* Additional information available at

Additional information available at

Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.

References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

All MMWR HTML versions of articles are electronic conversions from typeset documents. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version ( and/or the original MMWR paper copy for printable versions of official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #